Delphine Charvin

1.3k total citations
20 papers, 1.0k citations indexed

About

Delphine Charvin is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Delphine Charvin has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 12 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Delphine Charvin's work include Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological disorders and treatments (6 papers). Delphine Charvin is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurological disorders and treatments (6 papers). Delphine Charvin collaborates with scholars based in France, United States and Canada. Delphine Charvin's co-authors include Rossella Medori, Olivier Rascol, Robert A. Hauser, Jocelyne Caboche, Christiane Pagès, Peter Vanhoutte, Marta García, Françoise Girard, Brice Campo and Emmanuel Le Poul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Delphine Charvin

20 papers receiving 989 citations

Peers

Countries citing papers authored by Delphine Charvin

Since Specialization

Citations

This map shows the geographic impact of Delphine Charvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delphine Charvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delphine Charvin more than expected).

Fields of papers citing papers by Delphine Charvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delphine Charvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delphine Charvin. The network helps show where Delphine Charvin may publish in the future.

Co-authorship network of co-authors of Delphine Charvin

This figure shows the co-authorship network connecting the top 25 collaborators of Delphine Charvin. A scholar is included among the top collaborators of Delphine Charvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delphine Charvin. Delphine Charvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Foliglurax, a positive allosteric modulator of the metabotrophic glutamate receptor 4, protects dopaminergic neurons in MPTP-lesioned male mice 2023 ·Brain Research ·Mélanie Bourque, Marc Morissette, François Conquet, Delphine Charvin, Thérèse Di Paolo	3
2	A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of l-Dopa-induced dyskinesia 2022 ·Neuropharmacology ·Valeria Calabrese, Barbara Picconi, Nicolas Heck, Federica Campanelli, Giuseppina Natale, Gioia Marino, Miriam Sciaccaluga, Veronica Ghiglieri, Alessandro Tozzi, (unknown), (unknown), Jocelyne Caboche, François Conquet, Paolo Calabresi, Delphine Charvin	6
3	mGlu4 allosteric modulation for treating Parkinson's disease 2018 ·Neuropharmacology ·Delphine Charvin	25
4	Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs 2018 ·Nature Reviews Drug Discovery ·Delphine Charvin, Rossella Medori, Robert A. Hauser, Olivier Rascol	209
5	Characterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman Primates 2018 ·Molecular Imaging and Biology ·Akihiro Takano, Sangram Nag, Zhisheng Jia, (unknown), Anton Forsberg, Ryosuke Arakawa, Per Grybäck, (unknown), Christer Halldin, Delphine Charvin	9
6	An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates 2018 ·Movement Disorders ·Delphine Charvin, Thérèse Di Paolo, Erwan Bézard, Laurent Grégoire, Akihiro Takano, (unknown), Elsa Y. Pioli, Christer Halldin, Rossella Medori, François Conquet	46
7	Erratum: Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs 2018 ·Nature Reviews Drug Discovery ·Delphine Charvin, Rossella Medori, Robert A. Hauser, Olivier Rascol	25
8	Discovery, Structure–Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 2017 ·Journal of Medicinal Chemistry ·Delphine Charvin, (unknown), Millán Ortiz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christophe Morice, Baptiste Manteau, Stanislas Mayer, Danielle Graham, (unknown), (unknown), Gaël Hédou, François Conquet, Stéphan Schann	38
9	A Novel mglur4 compound alleviates motor symptoms in primate models of parkinson's disease 2017 ·Journal of the Neurological Sciences ·Delphine Charvin, Thérèse Di Paolo, Erwan Bézard, Christer Halldin, (unknown), Laurent Grégoire, Akihiro Takano, Elsa Y. Pioli, R. Medori, François Conquet	1
10	A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine core 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Benjamin Perry, Emmanuel Le Poul, Sonia Poli, Béatrice Bonnet, Nathalie Lambeng, Delphine Charvin, (unknown), (unknown), Stefania Gagliardi, Jean‐Philippe Rocher	5
11	A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Sonia Poli, Delphine Charvin, Brice Campo, (unknown), (unknown), Bin Luo, (unknown), Lisa M. Hodge, Karen Smith, Anthony G. DiLella, Nigel J. Liverton, Fred Hess, Susan Browne, Ian J. Reynolds	76
12	ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Mikhail Kalinichev, Mélanie Rouillier, Françoise Girard, (unknown), Bruno Bournique, (unknown), Delphine Charvin, Brice Campo, Emmanuel Le Poul, Vincent Mutel, Sonia Poli, S. Neale, T.E. Salt, Robert Lütjens	86
13	Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation 2009 ·PLoS ONE ·Carole Deyts, Beatriz Galán-Rodríguez, Elodie Martin, (unknown), Emmanuel Roze, Delphine Charvin, Jocelyne Caboche, Sandrine Bétuing	51
14	Insulin‐like growth factor‐1 and neurotrophin‐3 gene therapy prevents motor decline in an X‐linked adrenoleukodystrophy mouse model 2009 ·Annals of Neurology ·(unknown), Jean‐Charles Bensadoun, Delphine Charvin, Patrick Aebischer, Aurora Pujol, Cédric Raoul	22
15	Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo 2007 ·Neurobiology of Disease ·Delphine Charvin, Emmanuel Roze, Valérie Perrin, Carole Deyts, Sandrine Bétuing, Christiane Pagès, Etienne Régulier, Ruth Luthi‐Carter, Emmanuel Brouillet, Nicole Déglon, Jocelyne Caboche	46
16	A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition 2006 ·Human Molecular Genetics ·Anne Couturier‐Tarrade, Coralie Fassier, (unknown), Delphine Charvin, Jérémie Vitte, Leticia Peris, Alain Thorel, Étienne Mouisel, Núria Fonknechten, Natacha Roblot, Danielle Seilhean, Andrée Dierich, Jean Jacques Hauw, Judith Melki	146
17	À la recherche d’un rôle de la dopamine dans la maladie de Huntington 2006 ·médecine/sciences ·Jocelyne Caboche, Delphine Charvin	1
18	Unraveling a role for dopamine in Huntington's disease: The dual role of reactive oxygen species and D2 receptor stimulation 2005 ·Proceedings of the National Academy of Sciences ·Delphine Charvin, Peter Vanhoutte, Christiane Pagès, (unknown), Jocelyne Caboche	102
19	Expanded huntingtin activates the C-JUN N TERMINAL KINASE/C-JUN pathway prior to aggregate formation in striatal neurons in culture 2004 ·Neuroscience ·Marta García, Delphine Charvin, Jocelyne Caboche	37
20	Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus 2003 ·Human Molecular Genetics ·Delphine Charvin	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact